Nkmax Co., Ltd.

Seongnam, South Korea nkmax.com

Overview

Nkmax Co., Ltd. is a South Korean biotechnology company that focuses on the development and commercialization of immunotherapeutic products. The company specializes primarily in natural killer (NK) cell therapies and aims to harness the power of the immune system to treat various diseases, including cancer.

Therapeutic areas

OncologyImmunotherapy

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Nkmax Co., Ltd. in our records. PharmaTek screens the full directory against live FDA enforcement data.

Related companies

Adventris Pharmaceuticals
United States
Alpha Oncology Therapeutics, Inc.
USA
Aulos Bioscience, Inc.
United States
Biomunex Pharmaceuticals
France
Biond Biologics Ltd.
Israel
Biontech Se
Germany
Cancer Research Innovations, Inc.
USA
Cancer Research Organization
United Kingdom

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo